|
Index of reports
> Cases resulting in hospitalization (13)
Below is the selection of adverse event reports related to MS Contin (Morphine) that includes cases resulting in hospitalization.
Adverse event in male receiving MS Contin (Morphine)
Reported by a consumer/non-health professional from United Kingdom on 2007-10-19
Patient: male, weighing 68.0 kg (149.6 pounds)
Adverse reactions / side effects: Blood Pressure Increased, Renal Impairment, Anorexia, Lymphangiosis Carcinomatosa, Constipation
Adverse event resulted in: death, hospitalization
Suspect drug(s):
Bevacizumab
Dosage: 5 mg/kg, q2w
Indication: Colorectal Cancer
Start date: 2005-12-07
End date: 2006-08-01
Fluorouracil
Dosage: 400 mg/ml, q2w
Indication: Colorectal Cancer
Start date: 2005-12-07
End date: 2006-08-02
Fluorouracil
Dosage: 600 mg/m2, q2w
Start date: 2005-12-07
End date: 2006-08-03
Leucovorin Calcium
Dosage: 100 mg/m2, q2w
Indication: Colorectal Cancer
Start date: 2005-12-07
End date: 2006-08-08
Oxaliplatin
Dosage: 85 mg/m2, q2w
Indication: Colorectal Cancer Metastatic
Start date: 2005-12-07
End date: 2006-08-01
MS Contin
Dosage: 60 mg, unk
Indication: Cancer Pain
Start date: 2006-01-07
Morphine HCL Elixir
Dosage: 10 mg, bid
Indication: Cancer Pain
Start date: 2005-11-30
Adverse event in male receiving MS Contin (Morphine)
Reported by a individual with unspecified qualification on 2007-06-22
Patient: male
Adverse reactions / side effects: Abnormal Behaviour, Disorientation
Adverse event resulted in: hospitalization
Suspect drug(s):
MS Contin (Morphine)
Adverse event in male receiving MS Contin (Morphine)
Reported by a individual with unspecified qualification on 2007-06-22
Patient: male
Adverse reactions / side effects: Abnormal Behaviour, Disorientation
Adverse event resulted in: hospitalization
Suspect drug(s):
MS Contin
Dosage: unk mg, see text
Indication: Procedural Pain
Oxymorphone Hydrochloride
Dosage: unk, unk
Indication: Bone Pain
Adverse event in male receiving MS Contin (Morphine)
Reported by a individual with unspecified qualification on 2007-06-22
Patient: male
Adverse reactions / side effects: Abnormal Behaviour, Disorientation
Adverse event resulted in: hospitalization
Suspect drug(s):
MS Contin
Dosage: unk mg, see text
Indication: Procedural Pain
Oxymorphone Hydrochloride
Dosage: unk, unk
Indication: Bone Pain
Adverse event in female receiving MS Contin (Morphine)
Reported by a individual with unspecified qualification on 2007-06-22
Patient: female
Adverse reactions / side effects: Abnormal Behaviour, Disorientation
Adverse event resulted in: hospitalization
Suspect drug(s):
MS Contin (Morphine)
Adverse event in female receiving MS Contin (Morphine)
Reported by a individual with unspecified qualification on 2007-05-23
Patient: female
Adverse reactions / side effects: Lymphadenopathy, Pruritus, Urticaria, Scleroderma, Pharyngeal Oedema, Connective Tissue Disorder, Abscess Limb, Cutaneous Lupus Erythematosus, Ligament Injury, Pelvic Mass, Pain in Extremity, Osteomyelitis Chronic, Osteitis, Vertebral Injury, Throat Irritation, Dehydration, Lymphoma, Pharmaceutical Product Complaint, Therapeutic Agent Toxicity, Pain, Impaired Work Ability, Constipation, Nasal Oedema, Road Traffic Accident, Adrenal Insufficiency, Myocardial Infarction, Medication Residue, Dyspnoea, Joint Dislocation, Uterine Cancer, Lung Disorder, Alopecia, Memory Impairment, Syncope Vasovagal, Immune System Disorder
Adverse event resulted in: hospitalization, disablity
Suspect drug(s):
MS Contin
Dosage: 60 mg, unk
Indication: Systemic Lupus Erythematosus
MS Contin
Dosage: 100 mg, bid prn
Adverse event in female receiving MS Contin (Morphine)
Reported by a individual with unspecified qualification on 2007-05-18
Patient: female
Adverse reactions / side effects: Pruritus, Lymphadenopathy, Urticaria, Scleroderma, Pharyngeal Oedema, Connective Tissue Disorder, Abscess Limb, Cutaneous Lupus Erythematosus, Pelvic Mass, Ligament Injury, Pain in Extremity, Osteomyelitis Chronic, Osteitis, Vertebral Injury, Throat Irritation, Dehydration, Pharmaceutical Product Complaint, Lymphoma, Pain, Impaired Work Ability, Therapeutic Agent Toxicity, Constipation, Nasal Oedema, Road Traffic Accident, Adrenal Insufficiency, Myocardial Infarction, Medication Residue, Dyspnoea, Joint Dislocation, Uterine Cancer, Lung Disorder, Alopecia, Memory Impairment, Immune System Disorder, Syncope Vasovagal
Adverse event resulted in: hospitalization, disablity
Suspect drug(s):
MS Contin (Morphine)
Adverse event in male receiving MS Contin (Morphine)
Reported by a individual with unspecified qualification on 2007-05-09
Patient: male
Adverse reactions / side effects: Overdose, Unevaluable Event
Adverse event resulted in: hospitalization
Suspect drug(s):
MS Contin
Indication: Drug USE FOR Unknown Indication
Narcan
Indication: Drug USE FOR Unknown Indication
Adverse event in 49 year old female receiving MS Contin (Morphine)
Reported by a health professional (non-physician/pharmacist) from United States on 2007-03-30
Patient: 49 year old female
Adverse reactions / side effects: Vomiting, Nausea, Gastroenteritis, Drug Withdrawal Syndrome, White Blood Cell Count Increased
Adverse event resulted in: hospitalization
Suspect drug(s):
MS Contin
Dosage: unk, unk
Indication: Drug USE FOR Unknown Indication
Start date: 2007-02-20
Fentanyl
Dosage: 800 mcg, prn
Indication: Breakthrough Pain
Start date: 2005-09-24
Other drugs received by patient: Cymbalta; Levsin; Synthroid; Humulin 70 / 30; Albuterol; Progesterone; Singulair; Flonase; Trileptal; Seroquel; Doxycycline; Nexium; Boniva; Astelin; Terazol 7; Vitamin CAP; Neurontin; Mobic; Miralax; Tricor
Adverse event in 72 year old male receiving MS Contin (Morphine)
Reported by a consumer/non-health professional from United States on 2007-03-01
Patient: 72 year old male, weighing 83.0 kg (182.6 pounds)
Adverse reactions / side effects: Dyspnoea, Dizziness, Pulmonary Embolism
Adverse event resulted in: hospitalization
Suspect drug(s):
MS Contin
Dosage: 15 mg, bid
Indication: Drug USE FOR Unknown Indication
Start date: 2006-10-31
Msir Capsules
Dosage: 15 mg, q4h prn
Indication: Drug USE FOR Unknown Indication
Start date: 2006-10-31
SU - 011, 248 (Sunitinib Malate)
Dosage: 50 mg, daily
Administration route: Oral
Indication: Prostate Cancer
Start date: 2006-10-31
End date: 2006-11-25
Tamsulosin HCL
Dosage: .4 mg, daily
Administration route: Oral
Indication: Drug USE FOR Unknown Indication
Start date: 2006-10-31
End date: 2006-11-25
Other drugs received by patient: Zoladex; Atenolol; Digoxin; Warfarin Sodium; Lisinopril
Adverse event in 47 year old female receiving MS Contin (Morphine)
Reported by a health professional (non-physician/pharmacist) from United States on 2007-02-21
Patient: 47 year old female, weighing 52.2 kg (114.8 pounds)
Adverse reactions / side effects: Phlebitis, Muscle Atrophy, Pain, Post Procedural Complication, Condition Aggravated, Appendicitis Perforated, Gangrene, Collapse of Lung, Haematotoxicity, Peritonitis, Complex Regional Pain Syndrome, Joint Sprain, Pleural Effusion
Adverse event resulted in: life threatening event, hospitalization
Suspect drug(s):
MS Contin
Dosage: 1 tablet twice daily-bid- po
Administration route: Oral
Indication: Complex Regional Pain Syndrome
Start date: 2000-08-20
End date: 2007-02-20
Lotrel
Dosage: 1 tab daily po
Administration route: Oral
Indication: Hypertension
Start date: 2001-01-01
End date: 2007-02-20
Adverse event in 52 year old female receiving MS Contin (Morphine)
Reported by a individual with unspecified qualification on 2007-01-18
Patient: 52 year old female, weighing 63.0 kg (138.6 pounds)
Adverse reactions / side effects: Weight Decreased, Asthma, Abdominal Pain, Pyrexia, Loss of Consciousness, Pneumonia, Drug Abuser, Drug Withdrawal Syndrome, Delirium, Tremor, Paraesthesia, Dehydration, Anorexia, Disturbance in Attention, Vision Blurred, Pain, Disorientation, Somnolence, Speech Disorder, Myalgia, RED Blood Cell Count Decreased, Injection Site Reaction, Dizziness, Depression, Vomiting, Nausea, Dental Caries, Blood Potassium Decreased, Diarrhoea, Alopecia, Bronchitis, Memory Impairment, Asthenia
Adverse event resulted in: hospitalization
Suspect drug(s):
MS Contin
Dosage: unk, unk
Indication: Drug USE FOR Unknown Indication
Start date: 2005-09-25
PEG-Intron
Dosage: unk, unk
Indication: Hepatitis C
Start date: 2005-09-25
Ribasphere
Dosage: unk, unk
Indication: Hepatitis C
Start date: 2005-09-25
Other drugs received by patient: Aspirin; Buspar; Calcium; Glucosamine W / Chondroitin Sulfates; Hydromorphone HCL; Lecithin; Levothyroxine Sodium; Vitamin CAP; Omega-3; Promethazine; Vitamin A+D; Vitamin B Complex CAP; Ascorbic Acid; Vitamin E; Wellbutrin; Albuterol Sulate; Flaxseed OIL; Inderal; Epogen; Iron
Adverse event in 52 year old female receiving MS Contin (Morphine)
Reported by a individual with unspecified qualification from United States on 2007-01-16
Patient: 52 year old female, weighing 63.0 kg (138.6 pounds)
Adverse reactions / side effects: Weight Decreased, Abdominal Pain, Asthma, Pyrexia, Loss of Consciousness, Injection Site Erythema, Pneumonia, Drug Abuser, Injection Site Bruising, Drug Withdrawal Syndrome, Delirium, Tremor, Paraesthesia, Respiratory Tract Congestion, Anorexia, Dehydration, Vision Blurred, Disturbance in Attention, Pain, Injection Site Swelling, Disorientation, Somnolence, Speech Disorder, Myalgia, RED Blood Cell Count Decreased, Injection Site Reaction, Dizziness, Depression, Vomiting, Nausea, Dental Caries, Burning Sensation, Diarrhoea, Blood Potassium Decreased, Alopecia, Bronchitis, Memory Impairment, Asthenia
Adverse event resulted in: hospitalization
Suspect drug(s):
PEG-Intron
Dosage: unk, unk
Indication: Hepatitis C
Start date: 2005-09-25
Ribasphere
Administration route: Oral
Indication: Hepatitis C
Start date: 2005-09-25
MS Contin
Dosage: unk, unk
Indication: Drug USE FOR Unknown Indication
End date: 2005-10-01
MS Contin
Start date: 2005-01-01
MS Contin
End date: 2005-09-25
Other drugs received by patient: Aspirin; Buspar; Calcium; Glucosamine W / Chondroitin Sulfates; Hydromorphone HCL; Inderal; Lecithin; Levothyroxine Sodium; Morphine Sulfate; Vitamin CAP; Omega-3; Promethazine; Vitamin A and D; Vitamin B Complex CAP; Ascorbic Acid; Vitamin E; Wellbutrin; Morphine Sulfate; Flaxseed OIL; Calcium; Albuterol; Epogen; Iron; Inderal; Doxycycline Hydrochloride
|
